Regulatory Show all
December 16 | 2024

2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of commercial expansion of breakthrough precision oncology products

Read more
June 18 | 2024

2CUREX APPOINTS OLE THASTRUP AS NEW CEO

Read more
December 29 | 2023

2cureX announces changes to the management

Read more
July 1 | 2022

Dr. Raphael Gruber joins 2cureX as new Medical Director

Read more
May 12 | 2022

2cureX AB nominates Dr. Michael Schaefer to the Board of Directors

Read more
May 12 | 2022

2cureX AB nominerar Dr. Michael Schaefer till styrelsen

Read more
April 21 | 2022

Manuel Fernández joins 2cureX as Director of Quality Assurance and Regulatory Affairs.

Read more
February 23 | 2022

2cureX reorganizes to an even stronger distributor focus

Read more
June 22 | 2021

2cureX appoints 2 new VPs for its Commercial Operations

Read more
January 28 | 2021

2cureX appoints Kenneth Graabek Johansen, an experienced business and financial executive, as new CFO.

Read more
January 5 | 2021

2cureX appoints Fernando Andreu, an international Biotech executive, as new CEO

Read more
July 3 | 2020

2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner

Read more
July 3 | 2020

2cureX AB expands its Board of Directors with Michael Lutz and Nils Brünner

Read more
June 20 | 2019

2cureX appoints Dr. Med. Henrik Harling as Chief Medical Officer

Read more
June 20 | 2019

2cureX utser Dr. Henrik Harling till Chief Medical Officer

Read more
January 16 | 2019

2cureX strengthens the organisation via the recruitment of a CFO

Read more
January 16 | 2019

2cureX stärker organisationen genom rekrytering av CFO

Read more